Larimar Therapeutics (LRMR) Stock Chart & Stock Price History $1.90 +0.07 (+3.53%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$1.90 -0.01 (-0.52%) As of 04/17/2025 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Larimar Therapeutics Stock Price Performance 5 Day Performance+1.33%1 Month Performance-24.10%3 Month Performance-42.96%6 Month Performance-75.45%Year-To-Date Performance-50.78%1 Year Performance-70.83% Receive LRMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address LRMR Stock Chart for Sunday, April, 20, 2025 LRMR Chart by TradingView Larimar Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$1.91$1.91$1.97$1.861.09 million shs$121.97 million04/17/2025$1.84$1.91+3.53%$1.97$1.861.09 million shs$121.97 million04/16/2025$1.88$1.84-2.13%$1.87$1.76517,441 shs$117.81 million04/15/2025$1.87$1.88+0.53%$1.91$1.85438,414 shs$120.37 million04/14/2025$1.81$1.87+3.31%$1.90$1.82565,082 shs$119.73 million04/11/2025$1.78$1.81+1.69%$1.86$1.73544,187 shs$115.89 million04/10/2025$1.88$1.78-5.32%$1.88$1.72601,233 shs$113.97 million04/09/2025$1.71$1.88+9.94%$1.93$1.612.21 million shs$120.37 million04/09/2025$1.71$1.88+9.94%$1.93$1.612.21 million shs$120.37 million04/08/2025$1.87$1.71-8.56%$1.99$1.68611,041 shs$109.49 million Get the Latest News and Ratings for LRMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$1.87$1.71-8.56%$1.99$1.68611,041 shs$109.49 million04/07/2025$1.96$1.87-4.59%$1.98$1.74748,569 shs$119.73 million04/04/2025$1.98$1.96-1.01%$1.97$1.85810,008 shs$125.50 million04/03/2025$2.20$1.98-10.00%$2.13$1.97656,318 shs$126.78 million04/02/2025$2.00$2.20+10.00%$2.20$1.921.63 million shs$140.86 million04/01/2025$2.15$2.00-6.98%$2.12$1.96927,902 shs$128.06 million03/31/2025$2.35$2.15-8.51%$2.26$2.071.02 million shs$137.66 million03/28/2025$2.38$2.35-1.05%$2.37$2.25986,346 shs$149.95 million03/27/2025$2.25$2.38+5.56%$2.44$2.212.17 million shs$151.54 million03/26/2025$2.31$2.25-2.60%$2.32$2.19975,420 shs$143.57 million03/25/2025$2.28$2.31+1.32%$2.36$2.221.51 million shs$147.39 million03/24/2025$2.54$2.28-10.24%$2.61$2.251.37 million shs$145.48 million03/21/2025$2.51$2.54+1.20%$2.56$2.44655,389 shs$162.07 million03/20/2025$2.57$2.51-2.33%$2.60$2.49476,007 shs$160.16 million03/19/2025$2.37$2.57+8.44%$2.61$2.391.29 million shs$163.98 million Related Companies GH Research Stock Price Chart Kura Oncology Stock Price Chart CorMedix Stock Price Chart Sage Therapeutics Stock Price Chart Cullinan Therapeutics Stock Price Chart Maravai LifeSciences Stock Price Chart Tyra Biosciences Stock Price Chart SIGA Technologies Stock Price Chart Relay Therapeutics Stock Price Chart Akebia Therapeutics Stock Price Chart Receive LRMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LRMR) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Larimar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.